Processing .....please wait.. 
The article has been forwarded.... 
News >> Technology >>
HCL Tech, IIT Delhi join hands for drug research
By agencies
|
Wednesday, 04 May 2005, 19:30 IST
NEW DELHI: HCL Technologies has signed a Memorandum of Understanding (MoU) with Supercomputing facility for Bioinformatics and Computational Biology (SCFBio) at IIT-Delhi to work collaboratively on high-end projects in drug discovery and development, including genomics and proteomics projects.
''We are developing next generation medical devices, drug development tools utilizing IP protected molecular designing algorithms, clinical data and trial management solutions. By such associations in the area of pharma R&D, we are strengthening our domain capabilities for global markets,'' Pradeep Nair, Head of HCL's Life Sciences practice, said in a statement here.
SCFBio is dedicated to developing scientific methods and new software for genome analysis, protein structure prediction and active site-directed drug design. This partnership will also provide the researchers access to HCL's software development expertise.
''HCL will use its CMMI processes and robust software design methodology to leverage the domain expertise of the team at IIT Delhi,'' he said.
HCL plans to team up with premier Bioinformatics research institutions across the world to build fundamental capabilities and grow talent pool in India in this domain.
HCL has set up India's first network dedicated to Bioinformatics research - Biogrid. Currently, 12 research institutes are using this network to collaborate on research projects. This network would help the scientists and students across the country to access Supercomputing resources from any of these centers.